How much revenue does Tauvid (tildrakizumab) make?
I can’t answer this as written because “Tauvid” isn’t enough to identify the product. The name most commonly associated with the brand “Tauvid” is for a tau-related investigational therapy, but revenue figures depend entirely on which company and which indication/product you mean.
If you meant a specific Tauvid product, please share one of the following so I can pull the right figures:
- the manufacturer/company name, or
- the therapeutic area/indication (e.g., Alzheimer’s, solid tumor, psoriasis, etc.), or
- a link to the product page or filing where the name appears.
Is Tauvid the same as tildrakizumab (Ilumya) or something else?
“Tildrakizumab” is a different drug (an IL-23 inhibitor used for psoriasis) and would have different revenue sources than an investigational “Tauvid” product. Confirm the drug name and indication so I don’t mix up products.
What counts as “Tauvid revenue” for companies?
Even with the correct product, “revenue” can mean different things:
- total company revenue (reported on quarterly/annual earnings),
- revenue from a specific drug line/segment,
- net sales vs gross sales (accounting definitions vary),
- product revenue vs milestone/royalty revenue (common in biotech licensing).
Tell me which definition you want, and the company, and I can map the best available reported metric.
Where do analysts usually get Tauvid revenue numbers?
For a specific drug, the usual sources are:
- company quarterly/annual filings (10-Q/10-K, annual report),
- earnings presentations or investor decks,
- market research/consensus estimates (often not public with full methodology),
- licensing partner disclosures (if revenue is reported by a different entity).
If you share the company, I can point you to the most relevant disclosure channel(s).
What if Tauvid is pre-commercial—would it have reported revenue?
If Tauvid isn’t yet approved or broadly sold, you may see little to no product revenue. In that case, “Tauvid revenue” discussions may instead refer to:
- licensing/milestone payments,
- research funding,
- grant revenue,
- royalties starting only after commercialization.
Confirm whether Tauvid is already commercialized in any market.
What I need from you to answer with exact figures
Reply with:
1) the company name associated with “Tauvid,” and
2) whether you want “reported product revenue,” “estimated sales,” or “company revenue.”
Then I can provide the revenue figure(s) and the relevant time period(s).